Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 Amended and Restated Articles of Association of the Registrant, As Currently In Effect
- 4.3 Description of Securities
- 10.1 Form of Indemnification Agreement
- 10.6 2017 Share Incentive Plan, As Amended
- 10.15 Employment Agreement, Dated November 20, 2017, by and Between Gamida Cell Inc. and DR. Julian Adams
- 10.16 Employment Agreement, Dated December 15, 2021, by and Between Gamida Cell Inc. and Shai Lankry
- 10.17 Employment Agreement, Dated July 20, 2020, by and Between Gamida Cell Inc. and Michele Korfin
- 10.18 Employment Agreement, Dated April 30, 2017, by and Between Gamida Cell Inc. and Ronit Simantov
- 10.19 Consulting Agreement, Dated January 7, 2020, by and Between Gamida Cell Limited and Uppal Healthcare Limited
- 23.1 Consent of Kost, Forer, Gabbay & Kasierer, a Member of Ernst & Young Global, Independent Registered Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
Related press release
Associated GMDAQ transcripts
GMDAQ similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Gamida Cell Ltd. (the “Company”) on Form 10-K for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Shai Lankry, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 24, 2022.
/s/ Shai Lankry | |
Shai Lankry | |
Chief Financial Officer |